| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2543141 | Journal of the American Pharmacists Association | 2015 | 4 Pages |
Abstract
Rhabdomyolysis was observed possibly because of a drug interaction between once-daily ticagrelor and atorvastatin 80Â mg. Clinicians need to be aware of this possible drug interaction via CYP3A4 and potential complications.
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
Kazuhiko PharmD, Mary B. (Cardiology Pharmacy Specialist), Arash (Third-Year Fellow in Cardiology), Alison (Associate Professor of Medicine), Jonathan A. (Critical Care Pharmacist),